FATE
Fate Therapeutics Inc
$4.78
Earnings Summary
Revenue | $1.68Mn |
Net Profits | $-44.12Mn |
Net Profit Margins | -2632.58% |
Highlights
Fate Therapeutics Inc’s revenue fell -96.22% since last year same period to $1.68Mn in the Q4 2023. On a quarterly growth basis, Fate Therapeutics Inc has generated -13.79% fall in its revenue since last 3-months.
Fate Therapeutics Inc’s net profit jumped 8.66% since last year same period to $-44.12Mn in the Q4 2023. On a quarterly growth basis, Fate Therapeutics Inc has generated 2.32% jump in its net profits since last 3-months.
Fate Therapeutics Inc’s net profit margin fell -2317.26% since last year same period to -2632.58% in the Q4 2023. On a quarterly growth basis, Fate Therapeutics Inc has generated -13.3% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Fate Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.49 |
EPS Estimate Current Year | -0.49 |
Highlights
Fate Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.49 - a 5.77% jump from last quarter’s estimates.
Fate Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.49.
Key Ratios
Key ratios of the Fate Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.45 |
Highlights
Fate Therapeutics Inc’s earning per share (EPS) jumped 22.41% since last year same period to -0.45 in the Q4 2023. This indicates that the Fate Therapeutics Inc has generated 22.41% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-26 | -0.52 | -0.45 | 13.46% |
2023-08-08 | -0.59 | -0.54 | 8.47% |
2023-05-03 | -0.62 | -0.19 | 69.35% |
2023-11-08 | -0.57 | -0.46 | 19.3% |
₹0 US Stocks a/c Opening Fee